Why Attend Agenda Agenda Subject to Change. All Times are Eastern Time. CLE Tuesday, May 18 Amy Comstock Rick, President & CEO, FDLI Stuart M. Pape, Senior Partner, Polsinelli PC and Co-Chair, 2021 FDLI Annual Conference Janet [...]
New, Emerging, and Continually Interesting Issues Discuss emerging issues in transitional biologics, FDA protein definition, labeling carve-outs and carve-ins, authorized biosimilars, advertising and promotion draft guidance, purple book reform, and FDA’s umbrella policy for Reference Product (RP) exclusivity. Scott M. Lassman , Principal, Lassman Law + Policy SCOTT M. [...]
Update Magazine | Spring 2021
Why Attend Agenda CLE Continuing Legal Education
Why Attend Agenda CLE Subject to Change Wednesday, March 24 11:20 – 11:40 AM Technology and Connection Support Session First virtual conference? Unsure about technology? Join FDLI staff for this informal, open session to make sure your audio and technology are prepared for [...]
Softbound | 230 pages
After the Juice Wars: The Post-POM Wonderful Legal Landscape and its Implications for FDA-Regulated Industries Rachel Simon ABSTRACT Five years have passed since POM Wonderful LLC v. Coca-Cola Co. established that the Federal Food, Drug, and Cosmetic Act (FDCA) does not preclude Lanham Act claims targeting FDA-regulated beverages. Few scholars, however, have evaluated the [...]
Why Attend Agenda CLE Tuesday, December 15 11:30 – 11:45 AM FDLI Welcome and Introductions Amy Comstock Rick, President & CEO, FDLI Sonali P. Gunawardhana, Of Counsel, Shook, Hardy & Bacon LLP and Chair, 2020 Enforcement, Litigation, and Compliance Conference 11:45 AM –12:15 PM Keynote Address Daniel Feith, Deputy [...]
Why Attend Agenda CLE Continuing Legal Education
FDLI Committee Invitation Response Form
